Clinical trial · Observational
Relations Between Cognitive Complaints and Cognitive Scores Goals in Cancer: Assessment of Metamemory
NCT02212132CI-TRIAL-00018772completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This pilot study is, in this new and original approach in cancer pathology, measure and explain the correspondence between perceived cognitive impairment (cognitive complaint) by cancer patients and their cognitive scores goals with tasks metamemory while controlling the anxiety and depression and fatigue factors of patients.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Memory Complaints | — | UNRESOLVED | — |
| Metamemory | — | UNRESOLVED | — |
| Performance Mnemonic | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| behavioral assessments | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patient
- description
- Neuropsychological evaluation, psychopathological assessment and fatigue
- interventionNames
- Other: behavioral assessments
- label
- Control group
- description
- Neuropsychological evaluation, psychopathological assessment and fatigue
- interventionNames
- Other: behavioral assessments
Primary outcomes (1)
- measure
- Evaluation of metamemory through questionnaires
- timeFrame
- At study entry
- description
- Comparison with questionnaires completed by healthy subjects matched controls.
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Patient being treated for a solid or hematologic malignancy; * Patients under 65 years of age; * Patients Grade 3 'end primary school "minimum (scale Barbizet); * Primary cancer of the central nervous system or brain metastases Absence; * No major cognitive disorders; * Lack of previous neurological; * Lack of personality disorders and evolutionary psychiatric pathology. Exclusion Criteria: * Patients with paraneoplastic syndrome; * Scalable psychiatric pathology; * Refusal to participate; * Patients unable to meet the cognitive tests; * Use of drugs; * Heavy drinking.
References
Publications (0)
Data not yet available
No reference posted for this study.